Radiopharma arm to invest CAD 94.5M to double RUBY-FILL capacity

Capex & Operations View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹939.00

prior close

₹940.40

announcement price

After-mkt

timing

Nifty Microcap 250market+0.3%-1.2% vs market

Pharmaceuticals peers, median of 168sector-0.2%-0.8% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-2.1

15m

-1.4

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.3-1.2-0.2-0.8

Next day

+2.8+1.1+1.6-0.3+3.1

+1.2+1.3-0.1-0.4+1.6

-0.4+2.0-2.4-0.7+0.3

-0.6+0.3-0.9-1.2+0.6

-0.4+1.1-1.5-1.0+0.5

-0.9-3.2+2.4-4.2+3.3

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jubilant Pharmova's radiopharma business will invest CAD 94.5 million to double production capacity of its flagship product RUBY-FILL at its Kirkland, Quebec facility. The Canadian government will provide financial support of CAD 23.8 million. The company notes demand has been strong, with the RUBY-FILL customer base doubling in the last three years. The expansion will modernize the facility and double manufacturing capacity to meet growing global demand.

Likely market impact

Major capacity expansion backed by government support signals confidence in rising global demand, likely supporting future revenue growth.